Does Taking Victoza Cause Hair Loss? UK Medical Evidence

Does taking Victoza cause hair loss? Patients prescribed Victoza (liraglutide), a GLP-1 receptor agonist for type 2 diabetes and weight management, occasionally report hair thinning during treatment. Currently, hair loss is not listed as an established adverse effect in the Summary of Product Characteristics approved by the MHRA or EMA. The relationship remains unclear, with potential contributing factors including rapid weight loss, nutritional deficiencies, underlying metabolic conditions, or other medications. This article examines the evidence, explores possible mechanisms, reviews Victoza's established side effect profile, and provides practical guidance for patients experiencing hair changes whilst taking this medication.

Does Victoza Cause Hair Loss? Understanding the Connection

Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist widely prescribed for type 2 diabetes management and, in higher doses as Saxenda, for weight management. Patients occasionally report hair loss whilst taking Victoza, raising understandable concerns about whether the medication directly causes this symptom.

Currently, there is no official link established between Victoza and hair loss in the product's Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA). Hair loss is not listed amongst the known adverse effects in clinical trial data. Evidence is limited to case reports and spontaneous reporting, which cannot establish causation.

It is crucial to understand that correlation does not equal causation. Many factors can contribute to hair loss in people with type 2 diabetes, including the underlying metabolic condition itself, nutritional deficiencies, stress, rapid weight loss, or other concurrent medications. The relationship between Victoza and hair loss remains unclear and likely multifactorial.

This article examines the potential mechanisms that might explain hair changes during Victoza treatment, reviews the medication's established side effect profile, and provides practical guidance for patients experiencing hair loss. If you notice significant hair thinning whilst taking Victoza, it is important to discuss this with your GP or diabetes specialist rather than discontinuing treatment independently, as uncontrolled diabetes poses serious health risks. Suspected side effects can be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).

Why Hair Loss May Occur During Victoza Treatment

Whilst Victoza itself has not been demonstrated to directly damage hair follicles, several potential indirect mechanisms could hypothetically contribute to hair loss in patients taking this medication:

Rapid weight loss is perhaps the most plausible explanation. Victoza promotes satiety and reduces appetite, often leading to significant weight reduction—particularly when prescribed as Saxenda for obesity management. Sudden or substantial weight loss can trigger a condition called telogen effluvium, where hair follicles prematurely enter the resting phase, resulting in increased shedding 2–3 months later. This temporary hair loss typically resolves once weight stabilises.

Nutritional deficiencies may develop if reduced appetite leads to inadequate intake of essential nutrients. Hair growth requires sufficient protein, iron, zinc, biotin, and vitamins (particularly B vitamins and vitamin D). Patients experiencing nausea—a common Victoza side effect—may inadvertently consume less nutritious food, potentially affecting hair health over time.

Metabolic and hormonal changes associated with improved glycaemic control and weight loss might temporarily influence the hair growth cycle, though this mechanism is not well-established.

Underlying conditions common in diabetes patients can affect hair growth. Thyroid dysfunction should be investigated as a potential cause of hair loss. Poor circulation may affect hair growth, though this typically manifests as leg hair changes rather than scalp hair loss.

It is worth noting that many patients taking Victoza do not experience hair loss. Hair loss was not identified in clinical trials, and other common causes should be considered, including androgenetic alopecia (pattern hair loss), alopecia areata (autoimmune hair loss), traction alopecia (from tight hairstyles), or postpartum hair shedding.

What to Do If You Experience Hair Loss on Victoza

If you notice increased hair shedding or thinning whilst taking Victoza, do not stop your medication without medical advice. Uncontrolled diabetes carries significant risks including cardiovascular disease, kidney damage, and vision loss. Instead, take the following steps:

Contact your GP or diabetes specialist to discuss your concerns. They can assess whether the hair loss is likely related to Victoza, investigate alternative causes, and determine the most appropriate course of action. Your healthcare provider may:

• Arrange blood tests to check for nutritional deficiencies (iron, ferritin, vitamin B12, folate, vitamin D), thyroid function (TSH, free T4), and overall metabolic health

• Review your medication regimen to identify other potential contributing factors

• Assess the pattern and severity of hair loss to distinguish between telogen effluvium and other conditions such as androgenetic alopecia

• Evaluate your nutritional intake and weight loss trajectory

Optimise your nutrition by ensuring adequate protein intake (in line with the NHS Eatwell Guide, typically 0.75g per kilogram of body weight daily for most adults) and consuming a varied diet rich in iron (lean meat, pulses, dark leafy vegetables), zinc (nuts, seeds, wholegrains), and B vitamins. Higher protein intake (1.0-1.2g/kg/day) may be recommended by your healthcare provider in specific circumstances. Only consider supplements if deficiencies are confirmed by testing and under clinical supervision.

Manage the side effects of Victoza that might affect nutrition. If nausea is problematic, eating smaller, more frequent meals and avoiding fatty or spicy foods may help. Your doctor might adjust your dose or suggest anti-nausea medication.

Be patient—if hair loss is due to telogen effluvium from rapid weight loss, regrowth typically begins 3–6 months after the triggering event once your weight stabilises. In the meantime, gentle hair care practices (avoiding harsh treatments, excessive heat styling, and tight hairstyles) can minimise further damage.

Seek specialist referral if hair loss is severe, progressive, or accompanied by scalp changes, as this may warrant dermatological assessment.

Seek urgent medical attention if you experience severe, persistent upper abdominal pain (with or without vomiting)—stop taking Victoza immediately as this could indicate pancreatitis. Also contact your healthcare provider promptly if you experience significant gastrointestinal symptoms or signs of dehydration, as these can affect kidney function.

How Victoza Works and Its Common Side Effects

Understanding Victoza's mechanism of action helps contextualise its side effect profile. Liraglutide is a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones. It works by:

• Stimulating insulin secretion in a glucose-dependent manner (reducing hypoglycaemia risk)

• Suppressing glucagon release when blood glucose is elevated

• Slowing gastric emptying, which prolongs satiety and reduces post-meal glucose spikes

• Acting on appetite centres in the brain to reduce hunger and food intake

Victoza is administered once daily via subcutaneous injection, starting at 0.6mg for one week (for tolerability only, not effective for glycaemic control), then typically increasing to 1.2mg and if needed to 1.8mg depending on glycaemic response and tolerability.

According to the MHRA/EMC SmPC, side effects include:

Very common side effects (affecting more than 1 in 10 people):

• Nausea and diarrhoea—usually most pronounced during dose escalation and often improving over time

• Hypoglycaemia: particularly when combined with sulphonylureas or insulin (consider reducing doses of these medications when starting Victoza)

Common side effects (affecting between 1 in 10 and 1 in 100 people):

• Vomiting, constipation, abdominal pain

• Decreased appetite, dyspepsia (indigestion)

• Headache, dizziness

Uncommon side effects (affecting up to 1 in 100 people) include injection site reactions, increased heart rate, dehydration (secondary to gastrointestinal effects), and gallbladder disorders (cholelithiasis/gallstones and cholecystitis, which may be associated with weight loss).

Serious but rare adverse effects require immediate medical attention:

• Pancreatitis: If you develop severe, persistent abdominal pain (with or without vomiting), stop taking Victoza immediately and seek urgent medical assessment

• Thyroid C-cell tumours: Based on findings in rodent studies; human risk has not been established. Report any neck lumps or swallowing difficulties

• Severe allergic reactions: rash, difficulty breathing, or swelling

According to NICE guidance (NG28), GLP-1 receptor agonists like Victoza are recommended for type 2 diabetes when metformin and other oral agents provide inadequate glycaemic control, particularly in patients where weight loss would be beneficial. Regular monitoring of HbA1c, renal function, and treatment response is essential.

If you experience any concerning symptoms whilst taking Victoza, contact your healthcare provider promptly. Dehydration from gastrointestinal side effects can potentially worsen kidney function, so ensure adequate fluid intake. Never discontinue diabetes medication without medical supervision, as the risks of uncontrolled hyperglycaemia significantly outweigh most medication side effects.

Frequently Asked Questions